Managing Symptoms When MBC Spreads to the Bones
Bone is the most common site where MBC spreads, which can lead to pain and fractures. Click to read recommendations from experts and find clinical trials looking for ways to manage symptoms.
Managing Symptoms When MBC Spreads to the Bones
Bone is the most common site where MBC spreads, which can lead to pain and fractures. Click to read recommendations from experts and find clinical trials looking for ways to manage symptoms.
Targeting the Androgen Receptor in MBC
Androgen receptors play a role in breast cancer cell growth. Therefore, drugs that target androgen receptors are being studied in MBC clinical trials. Read about these drugs and how to find trials for AR+ breast cancer.
Miami Breast Cancer Conference 2024
The annual Miami Breast Cancer Conference was held March 7-10, 2024. Read for highlights from this meeting.
Prioritizing Your Mental Health When Living With MBC
Living with MBC can be both physically and mentally challenging. Read to learn why prioritizing your mental health is important and where to find help.
Decoding Clinical Trial Terms: Arms
This month, we continue our series by discussing trial “arms” and the difference between “control” and “experimental” arms.
Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC
Learn about how ADCs work and for research news about Dato-DXd.
Trial Alerts: Now Available on Metastatic Trial Search!
Read about our new feature, Trial Alerts, which are emails sent once a week when new trials posted on Metastatic Trial Search match your profile.
Managing Side Effects of ADCs
Hear from experts about strategies to help prevent or reduce side effects to increase the ability to stay on treatment and improve quality of life.
Leptomeningeal Disease: How is it Different from Brain Metastasis and How is it Treated?
Breast cancer can spread to the layers of tissue that line and protect the brain, called leptomeningeal disease (LD). Click to learn about current research studying how to treat and manage LD.